Product Images Fosinopril Sodium

This table provides a comparison of the incidence rates of clinical adverse events between Fosinopril Sodium and placebo in hypertension patients. The table shows that patients taking Fosinopril Sodium had a higher incidence of cough, dizziness, nausea, and vomiting compared to those taking the placebo. In addition, the table also provides information on the number of patients who discontinued the medication due to adverse events.*

This text presents a list of clinical adverse events reported in placebo-controlled trials related to heart failure. The adverse events include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, diarrhea, chest pain (non-cardiac), upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbances, and weakness. The incidence and discontinuation rates are also reported for each adverse event and for the drug Fosinopril Sodium versus the placebo.*

This is a description of Fosinopril Sodium Tablets 20mg manufactured by Cipla USA Inc. The tablets are prescribed to patients as a treatment for hypertension. The tablets contain Fosinopril Sodium USP and are round, white, and imprinted with 201/1G. The medication must be stored at room temperature and kept away from moisture. It should not be transferred to anyone other than the patient for whom it was prescribed. The batch number, production number, and expiration date of the medication are included for tracking purposes.*